Skip to content

Efficacy analysis for a novel hyperthermic intraperitoneal chemotherapy for incidental gallbladder cancer

Efficacy analysis for a novel hyperthermic intraperitoneal chemotherapy for incidental gallbladder cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900028155
Enrollment
Unknown
Registered
2019-12-13
Start date
2013-01-01
Completion date
Unknown
Last updated
2019-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

incidental gallbladder cancer

Interventions

Surgery alone vs surgery combined with thermochemotherapy:thermochemotherapy

Sponsors

Hepatobiliary Surgery, Henan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients undergoing laparoscopic cholecystectomy for benign lesions before surgery, and intraoperative or postoperative pathology suggesting gallbladder cancer

Exclusion criteria

Exclusion criteria: 1. can not expressed or understood informed consent; 2. unable or unwilling to complete communication research

Design outcomes

Primary

MeasureTime frame
Disease Free Survival;

Countries

China

Contacts

Public ContactQiang Tang

Hepatobiliary Surgery, Henan Provincial People's Hospital

jaketq@163.com+86 15939011212

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026